• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿司咪唑,一种H1拮抗剂,在类风湿性关节炎中没有额外的治疗效果。

Astemizole, an H1 antagonist, has no additional therapeutic effect in rheumatoid arthritis.

作者信息

Chard M D, Crisp A J

机构信息

Rheumatology Research Unit, Addenbrooke's Hospital, Cambridge, United Kingdom.

出版信息

J Rheumatol. 1991 Feb;18(2):203-4.

PMID:1673723
Abstract

Mast cells are found in increased numbers in the synovium of patients with rheumatoid arthritis (RA) and may play a role in synovitis. They produce proinflammatory substances including histamine. A double blind placebo controlled study was undertaken in 60 patients with active RA using the H1 receptor blocker, astemizole, as an adjuvant to usual therapies. After 3 months of treatment there were no significant differences in clinical and laboratory variables between the groups. We conclude that H1 antagonist treatment with astemizole has no additional therapeutic effect in RA.

摘要

在类风湿关节炎(RA)患者的滑膜中发现肥大细胞数量增加,且肥大细胞可能在滑膜炎中起作用。它们会产生包括组胺在内的促炎物质。一项双盲安慰剂对照研究对60例活动性RA患者进行,使用H1受体阻滞剂阿司咪唑作为常规治疗的辅助药物。治疗3个月后,两组之间的临床和实验室指标无显著差异。我们得出结论,阿司咪唑进行H1拮抗剂治疗对RA没有额外的治疗效果。

相似文献

1
Astemizole, an H1 antagonist, has no additional therapeutic effect in rheumatoid arthritis.阿司咪唑,一种H1拮抗剂,在类风湿性关节炎中没有额外的治疗效果。
J Rheumatol. 1991 Feb;18(2):203-4.
2
Astemizole in perennial allergic rhinitis with seasonal exacerbations: a placebo-controlled double-blind study.
Ann Allergy. 1989 Dec;63(6 Pt 1):493-4.
3
Astemizole--a new, non-sedating antihistamine for hayfever.阿司咪唑——一种用于治疗花粉热的新型非镇静性抗组胺药。
J Otolaryngol. 1985 Apr;14(2):85-8.
4
A double-blind comparative trial of astemizole and terfenadine for the treatment of hay fever.
Allerg Immunol (Paris). 1989 Dec;21(10):396-8, 400.
5
[Astemizole and terfenadine: comparison of their therapeutic effect in pollen rhinitis].
Rev Med Suisse Romande. 1987 Oct;107(10):857-61.
6
Double-blind multicenter controlled clinical study comparing the efficacy of picumast dihydrochloride versus astemizole and placebo in patients with seasonal allergic rhinitis.一项双盲多中心对照临床研究,比较盐酸匹卡司特与阿司咪唑及安慰剂治疗季节性变应性鼻炎患者的疗效。
Arzneimittelforschung. 1989 Oct;39(10A):1360-3.
7
Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action.
Ann Allergy. 1988 Dec;61(6):436-9.
8
[A new H1-blocking antihistamine. Critical review of pharmacological and clinical studies].
Minerva Med. 1988 Mar;79(3):219-27.
9
[Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients].[阿司咪唑与特非那定治疗慢性荨麻疹的比较。40例患者的随机双盲研究]
Z Hautkr. 1985;60 Suppl 1:50-5.
10
[Total review of all results collected worldwide with astemizole (Hismanal)].[对全球收集的所有阿司咪唑(息斯敏)结果的全面综述]
Z Hautkr. 1985;60 Suppl 1:29-42.

引用本文的文献

1
Mast cells as a target in the treatment of rheumatoid arthritis.肥大细胞作为类风湿关节炎治疗靶点的研究进展。
Inflammopharmacology. 1999;7(4):351-62. doi: 10.1007/s10787-999-0029-5.